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Structural basis for impairment of DNA
methylation by the DNMT3A R882H mutation
Hiwot Anteneh1, Jian Fang1 & Jikui Song 1✉
DNA methyltransferase DNMT3A is essential for establishment of mammalian DNA
methylation during development. The R882H DNMT3A is a hotspot mutation in acute
myeloid leukemia (AML) causing aberrant DNA methylation. However, how this mutation
affects the structure and function of DNMT3A remains unclear. Here we report structural
characterization of wild-type and R882H-mutated DNMT3A in complex with DNA substrates
with different sequence contexts. A loop from the target recognition domain (TRD loop)
recognizes the CpG dinucleotides in a +1 flanking site-dependent manner. The R882H
mutation reduces the DNA binding at the homodimeric interface, as well as the molecular link
between the homodimeric interface and TRD loop, leading to enhanced dynamics of TRD
loop. Consistently, in vitro methylation analyses indicate that the R882H mutation com-
promises the enzymatic activity, CpG specificity and flanking sequence preference of
DNMT3A. Together, this study uncovers multiple defects of DNMT3A caused by the R882H
mutation in AML.
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DNA methylation is an important epigenetic mechanismthat critically impacts cell proliferation and lineagecommitment during development1,2. In mammals, DNA
methylation mainly occurs at the C-5 position of cytosines within
CpG dinucleotides, accounting for 70–80% of all CpG sites in the
genome3. Mammalian DNA methylation is established by de
novo DNA methyltransferases DNMT3A and DNMT3B4, and
subsequently subjected to maintenance by DNA methyltransfer-
ase DNMT1 in a replication-dependent manner5. DNMT3A-
mediated DNA methylation is further regulated by DNMT3-like
protein (DNMT3L) during gametogenesis and embryogenesis6–8.
Dysregulation of DNA methylation is associated with various
human diseases9, such as cancers10,11. Among these, mutation of
DNMT3A has been identified in ~25% acute myeloid leukemia
(AML) patients12–15, which gives rise to aberrant DNA methy-
lation patterns and increased cell proliferation16–18, and corre-
lates with poor clinical outcome13.
DNMT3A R882H mutation represents the most frequent
DNMT3A missense mutation in AML13. Previous studies have
demonstrated that this mutation leads to CpG DNA hypo-
methylation and altered gene regulation in hematopoietic or
embryonic stem (ES) cells16,17,19. Consistently, it has been
reported that the R882H mutation impairs the enzymatic activity
of DNMT3A16,17,20–24, and destabilizes its tetrameric form
in vitro and in cells17,22,23. Furthermore, recent studies have
suggested that the R882H mutation may affect the relative
enzymatic preference of DNMT3A toward different CpG-
flanking sequences: in comparison with wild-type DNMT3A,
the R882H mutant shows stronger preference for the CG(G/A)
motif over the CG(T/C) motif as substrate25, which correlates
with the aberrant DNA methylation and gene expression in AML,
suggesting an off-targeting effect of the DNMT3A R882H
mutation that may contribute to AML pathogenesis21.
The structures of DNMT3A in complex with DNMT3L have
been reported, revealing that DNMT3A dimerizes through two
alternative interfaces: a DNMT3A–DNMT3A homodimeric
interface (a.k.a. RD interface) mediated by polar interactions and
a DNMT3A–DNMT3L interface (a.k.a. FF interface) mediated by
hydrophobic contacts24,26,27. Our recent study on the complex
between DNMT3A–DNMT3L and CpG DNA further demon-
strated that the DNMT3A–DNA interaction is mediated by three
distinct regions: a loop from the target recognition domain (TRD
loop), a loop from the catalytic core (catalytic loop) and the RD
interface of DNMT3A24. Notably, residue R836 from the TRD
loop forms a hydrogen bond with the CpG site, which contributes
to the CpG specificity of DNMT3A24. Structural analysis of the
DNMT3A–DNMT3L–DNA complex also confirmed a role of
R882, located on the RD interface, in DNA binding24. In addition,
an intramolecular hydrogen bond is formed between residues
R882 and S837, establishing a link between the TRD loop and RD
interface.
To gain further insights into the context-dependent DNA
methylation by DNMT3A and the mutational effect of R882H, we
determined the crystal structure of wild-type DNMT3A
(DNMT3AWT)–DNMT3L tetramer in complex with a CGA
motif-containing DNA, as well as R882H-mutated DNMT3A
(DNMT3AR882H)–DNMT3L tetramer in complex with CGA-
and CGT-containing DNAs. Our study reveals that the TRD loop
in the DNMT3AWT–DNMT3L–CGA DNA complex recognizes
the CpG site in a different mechanism than that in the previously
reported DNMT3AWT–DNMT3L–CGT DNA complex24, there-
fore uncovering the inherent conformational dynamics of the
TRD loop. The R882H mutation not only impairs the
protein–DNA contact at the RD interface, but also perturbs the
molecular interaction between the RD interface and the TRD
loop, leading to altered conformational flexibility of the TRD loop
and its context-dependent DNA contact. Consistently, in vitro
methylation analyses indicate that the R882H mutation impairs
both the CpG methylation efficiency and specificity of DNMT3A.
Together, these studies uncover a multifaceted defect of
DNMT3A caused by the R882H mutation.
Results
Structure of the DNMT3AWT–DNMT3L–CGA DNA complex.
Our previous study delineated the interaction between
DNMT3AWT–DNMT3L and DNA containing two CGT motifs24.
To further investigate how the sequence context of DNA sub-
strates affects DNMT3A-mediated DNA methylation, we set out
to determine the crystal structure of DNMT3AWT–DNMT3L
tetramer in complex with a CGA-containing DNA duplex. In
essence, we generated the DNMT3AWT–DNMT3L tetramer
using the MTase domain of DNMT3AWT and the C-terminal
domain of DNMT3L (Fig. 1a). The DNA substrate was prepared
by annealing of a self-complimentary 25-mer DNA in which the
cytosine within the CGA motif is replaced by a zebularine (Z), a
cytosine analogue28. The resulting DNA duplex harbors two
separate (ZpGpA) • (TpCpG) sites, mimic of two (CpGpA) •
(TpCpG) sites (denoted herein as CGA DNA) (Fig. 1b). The
crystal structure of the DNMT3AWT–DNMT3L–CGA DNA
(DNMT3AWT–CGA) complex, bound to cofactor byproduct
S-Adenosyl-L-homocysteine (SAH), was solved by Molecular
Replacement using the reported crystal structure of DNMT3AWT–
DNMT3L–CGT DNA (DNMT3AWT–CGT) complex (PDB
5YX2)24 as template. The resulting electron density map per-
mitted us to model the entire DNMT3A and DNA molecules. The
majority of DNMT3L was also modeled, except for a few loop
segments (residues 209–217, 314–317, 354–357 and 380–386).
The structure of the DNMT3AWT–CGA complex was refined to
2.40 Å resolution (Fig. 1c and Supplementary Table 1).
The structure of the DNMT3AWT–CGA complex resembles
that of the DNMT3AWT–CGT complex (Fig. 1c)24, with the
zebularines flipped into the active sites of the DNMT3AWT
molecules, stabilized via covalent linkage with catalytic cysteine
C710 of DNMT3AWT and hydrogen-bonding interactions with
other catalytic residues (Fig. 1c). The protein–DNA interaction is
mainly mediated by the TRD loop (residues 831–848), catalytic
loop (residues 707–721) and a segment at the RD interface
(residues 881–887) of DNMT3AWT (Fig. 1c and Supplementary
Fig. 1a, b). The TRD loop extends into the DNA major groove,
with residues T834 and N838 engaging water-mediated and direct
hydrogen-bonding interactions with the N7 and O6 atoms of G6,
respectively (Fig. 1d). Meanwhile, residue T835 forms a hydrogen
bond with the backbone phosphate of G6, and the side chain of
residue R836 approaches the +1 – +3 flanking nucleotides (A7-
T8 and G9′) of the CpG site, donating the guanidinium group for
hydrogen-bonding interactions with A7 and T8 of the target
strand and G9′ of the non-target strand (Fig. 1d). Toward the
minor groove, the catalytic loop interacts with the unpaired CpG
guanine (G5′/G20) and surrounding DNA backbone through
hydrogen-bonding interactions, as well as stacking contacts
between residues V716 and P718 and ZpG guanine (G6/G19′)
(Fig. 1e). In addition, residues S881, R882, L883, and R887 at the
RD interface interact with the DNA backbone (T14-G16 and G9′-
T11′) through hydrogen bonding, electrostatic or van der Waals
contacts (Fig. 1f). Together, these interactions form three-
pronged contacts between DNMT3A dimers and DNA, resulting
in a buried surface area of ~2800 Å2. On the other hand,
DNMT3L is not involved in any contact with DNA, as observed
previously24.
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Structural comparison of DNMT3AWT–CGA and DNMT3AWT–
CGT. Structural comparison of DNMT3AWT–CGA with
DNMT3AWT–CGT reveals high structural similarity over the entire
complex, with root-mean-square deviation (RMSD) of 0.42 Å over
821 aligned Cα atoms (Fig. 2a). Nevertheless, the DNMT3AWT–
CGA complex differs considerably from the DNMT3AWT–CGT
complex in two regions: the TRD loop and the RD interface
(Fig. 2b,c). In the DNMT3AWT–CGT complex, the side chain of
residue R836 on the TRD loop forms a base-specific hydrogen bond
with G6, while the neighboring N838 forms a hydrogen bond with
the DNA backbone (Supplementary Fig. 1c); in contrast, in the
DNMT3AWT–CGA complex, the side chain of R836 flips away
from G6 to interact with the +1 – +3 flanking nucleotides through
hydrogen-bonding interactions; meanwhile, the side chain of N838
turns to occupy the space vacated by the flipped R836, thereby
engaging a base-specific hydrogen-bonding interaction with G6
(Fig. 2b and Supplementary Fig. 1d). Such a conformational rear-
rangement in the TRD loop also perturbs the interaction between
the RD interface and the TRD loop (Fig. 2b): the hydrogen bond
formed between the side chain of R882 and the backbone carbonyl
of S837 in the DNMT3AWT-CGT complex becomes disrupted in
the DNMT3AWT–CGA complex (Fig. 2b). Given that our previous
study indicated that the TRD loop undergoes a disorder-to-order
transition upon substrate binding, with the substrate-bound
form partially stabilized by the interaction between the TRD loop
and RD interface24, we surmised that loss of the hydrogen bond
between S837 and R882 in the DNMT3AWT–CGA complex would
presumably lead to enhanced flexibility of the TRD loop. Indeed, B-
factor analysis of the two DNMT3AWT-DNA complexes indicates
that whereas residues R836-N838 in the DNMT3AWT–CGT
complex are associated with an averaged B-factor (66.5 Å2), which
is comparable with the overall averaged B-factor of DNMT3A
(62.5 Å2), the same region in the DNMT3AWT–CGA complex is
associated with an averaged B-factor (87.7 Å2) significantly higher
than the overall averaged B-factor (70.9 Å2), supporting the
enhanced flexibility of the TRD loop in the DNMT3AWT–CGA
complex.
In line with the perturbation of the interaction between the
TRD loop and RD interface, structural comparison of the
DNMT3AWT–CGA and DNMT3AWT–CGT complexes also
reveals a subtle conformational change in the RD interface
(Fig. 2c). In the DNMT3AWT–CGT complex, residues S881,
R882, L883, and R887 on the RD interface all engage side-chain
hydrogen-bonding or van der Waals interactions with DNA
b
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Fig. 1 Structure of the DNMT3AWT–DNMT3L tetramer in complex with CGA DNA. a Domain architecture of DNMT3A and DNMT3L with the C-terminal
domains marked with arrowheads. The site for R882H mutation is marked. b DNA sequence (CGA) used for the structural study. Z, zebularine. c Ribbon
representations of DNMT3AWT–DNMT3L bound to CGA DNA and SAH, with residue R882 marked. The zebularines anchored at the two active sites are
shown in expanded views, with hydrogen-bonding interactions depicted as dashed lines and Fo–Fc omit map (violet) contoured at 2.0 sigma level. The SAH
molecules are shown in sphere representation. d–f Close-up views of the DNA interactions of the TRD loop (d), catalytic loop (e) and RD interface (f) of
DNMT3AWT.
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backbone (Fig. 2c, d), resulting in a buried surface area of 423 Å2.
By contrast, in the DNMT3AWT–CGA complex, although
residues S881 and L883 retain the same fashion of DNA
interactions, the other two residues, R882 and R887, are no
longer within a distance for hydrogen bond formation with the
DNA backbone (Fig. 2c, e), leading to a reduced buried surface
area (289 Å2) in this region.
Together, these observations suggest that the CpG sites
with different flanking sequences may result in different
CpG-recognition modes of the TRD loop, as well as
perturbation of the interaction between the TRD loop and
the RD interface.
Structure of the DNMT3AR882H–CGA DNA complex. To
understand how the R882H mutation of DNMT3A affects its
structure and function, we determined the crystal structure of
the complex between the DNMT3AR882H–DNMT3L tetramer
and CGA DNA (DNMT3AR882H–CGA), containing the same
sequence as that for the DNMT3AWT–CGA complex, and SAH
at 2.5 Å resolution (Fig. 3a and Supplementary Table 1).
Structural alignment of the entire DNMT3AR882H-CGA com-
plex with the DNMT3AWT–CGA complex gives an RMSD of
0.29 Å over 875 aligned Cα atoms, suggesting that the R882H
mutation does not alter the structural integrity of the
DNMT3A–DNMT3L tetramer (Fig. 3a). The most notable
a
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Fig. 2 Structural comparison of the DNMT3AWT–CGA and DNMT3AWT–CGT complexes. a Structural superposition of the DNMT3AWT–CGA and
DNMT3AWT–CGT (PDB 5YX2) complexes. b Structural comparison of the TRD loop and its interactions with CpG guanine (G6) and R882 in the
DNMT3AWT–CGA and DNMT3AWT–CGT complexes. The conformational rearrangements of the TRD residues between the two complexes are indicated
by arrows. c Structural comparison of the RD interface between the DNMT3AWT–CGA and DNMT3AWT–CGT complexes. d,e Close-up views of the R882-
and R887-engaged DNA interactions in the DNMT3AWT–CGT (PDB 5YX2) (d) and DNMT3AWT–CGA (e) complexes, with the Fo–Fc omit map (violet)
contoured at 2.0 sigma level. The distances for hydrogen-bonding and electrostatic interactions are measured and indicated by dashed lines, colored in red
and black, respectively.
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structural difference between the DNMT3AWT–CGA and
DNMT3AR882H–CGA complexes lies in the DNA conforma-
tion: In comparison with the DNMT3AWT–CGA complex,
the central segment of the DNMT3AR882H-bound DNA
molecule bends away by ~2 Å from the RD interface in the
DNMT3AR882H–CGA complex (Fig. 3b and Supplementary
Fig. 2a). The protein–DNA contact at the RD interface of
DNMT3AR882H in the CGA DNA complex is mainly mediated
by residues S881, H882, and L883, which form hydrogen bonds
and/or van der Waals contacts with the DNA backbone (Sup-
plementary Fig. 2b,c). The fact that the DNMT3AR882H–CGA
complex was crystalized under acidic condition (pH 4.2; see
Methods) likely contributed to the H882-mediated hydrogen-
bonding interaction. In addition, the side chain of R887 is
poised for electrostatic interaction with the backbone phos-
phate of A15/A10′ (Supplementary Fig. 2c). Together, these
interactions lead to a buried surface area of 238 Å2 in this
region, lower than that for the DNMT3AWT–CGA complex,
suggesting that the R882H mutation leads to reduced protein–
DNA contact at the RD interface.
The TRD loop in the DNMT3AR882H–CGA complex adopts a
similar conformation to that in the DNMT3AWT–CGA complex,
with residue N838 engaging a base-specific hydrogen-bonding
interaction with G6, and R836 forming hydrogen bonds with the
+2 (T8) and +3 (G9′) flanking bases (Fig. 3c, d). Nevertheless,
subtle conformational shift was observed for G9′, likely resulting
from the altered DNA curvature (Fig. 3c). In addition, residues
T834 and T835 both engage DNA contacts in the same fashion as
their counterparts in the DNMT3AWT–CGA complex (Fig. 3c).
Furthermore, as with the DNMT3AWT–CGA complex, the
hydrogen bond between the side chain of R882 and the backbone
carbonyl of S837 is also abrogated in the DNMT3AR882H–CGA
complex (Fig. 3c). Accordingly, residues R836-N838 are asso-
ciated with a significantly higher averaged B-factor (80.7 Å2) than
that averaged for the entire DNMT3AR882H molecule (65.2 Å2),
indicating the significant conformational dynamics of the TRD
loop in the DNMT3AR882H–CGA complex.
Crystal structure of the DNMT3AR882H–CGT DNA complex.
Next, to elucidate how the R882H mutation influences the context-
dependent DNA methylation by DNMT3A, we characterized the
structure of the DNMT3AR882H–DNMT3L tetramer in complex
with SAH and CGT-containing DNA (DNMT3AR882H–CGT),
with the same sequence as that previously used for crystalizing the
DNMT3AWT–CGT complex24 (Supplementary Fig. 3a). The
structure of the DNMT3AR882H–CGT complex was solved at 2.6 Å
resolution (Fig. 4a and Supplementary Table 1), well aligned with
that of the DNMT3AWT–CGT complex, with an RMSD of 0.37 Å
over 849 aligned Cα atoms (Fig. 4a).
Structural comparison of the DNMT3AR882H–CGT and
DNMT3AWT–CGT complexes again reveals a difference in the
DNA conformation: relative to the DNMT3AWT-bound DNA, the
DNMT3AR882H-bound DNA moves away from the RD interface
by ~3 Å, reflective of reduced protein–DNA contact (Fig. 4a).
Indeed, protein residues on the RD interface engage much reduced
protein–DNA contacts in the DNMT3AR882H–CGT complex than
the corresponding region in the DNMT3AWT–CGT complex
(Fig. 4b and Supplementary Fig. 3b,c). Of particular note, the side
chains of residues H882 and R887 in the DNMT3AR882H–CGT
complex are positioned further away from the DNA backbone
than their counterparts in the DNMT3AWT–CGT complex
a
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Fig. 3 Structural comparison of the DNMT3AWT–CGA and DNMT3AR882H–CGA complexes. a Structural superposition of the DNMT3AWT–CGA and
DNMT3AR882H–CGA complexes. b Structural comparison of the RD interface between the DNMT3AWT–CGA and DNMT3AR882H–CGA complexes.
c Structural comparison of the TRD loop and its interactions with CpG guanine (G6) and R882 in the DNMT3AWT–CGA and DNMT3AR882H–CGA
complexes. The hydrogen-bonding interactions are indicated by dashed lines. The conformational difference of G9′ is validated by the Fo–Fo difference
map (salmon) between the two complexes, contoured at 1.0 sigma level. d Close-up views of the DNA interactions of the TRD loop in the
DNMT3AR882H–CGA complex, with the Fo–Fc omit map (violet) contoured at 2.0 sigma level. The water molecule is shown as a red sphere.
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(Fig. 4b and Supplementary Fig. 3c). As a result of these structural
changes, protein–DNA contact at the RD interface in the
DNMT3AR882H–CGT complex accounts for a buried surface area
of ~206 Å2 only, much less than that for the DNMT3AWT–CGT
complex.
The molecular environment for the TRD loop between the
DNMT3AR882H–CGT and DNMT3AWT–CGT complexes also
appears distinct: First, as in the DNMT3AR882H–CGA complex,
the intramolecular hydrogen bond formed between residues S837
and R882 in the DNMT3AWT–CGT complex becomes abolished
in the DNMT3AR882H–CGT complex (Fig. 4c). Second, the DNA
molecules in the DNMT3AR882H–CGT and DNMT3AWT–CGT
complexes show differential extent of helical twist (Fig. 4c): In
comparison with the DNMT3AWT–CGT complex, the DNA
major groove in the DNMT3AR882H–CGT complex is positioned
further away from the TRD loop (Fig. 4c). In line with these
environmental changes, the DNMT3AR882H–CGT and the
DNMT3AWT–CGT complex manifests distinct dynamics on the
TRD loop: the electron density for the side chains of R836 and
N838 in the DNMT3AR882H–CGT complex becomes either
barely traceable or significantly reduced than their counterpart
in the DNMT3AWT–CGT complex (Fig. 4d,e). Consistently, the
averaged B-factor for residues R836-N838 (119.8 Å2) is signifi-
cantly higher than the overall averaged B-factor (89.9 Å2) of
DNMT3AR882H in the DNMT3AR882H–CGT complex. It is worth
noting that the overall B-factor of DNMT3AR882H in the
DNMT3AR882H–CGT complex is also much higher than that of
DNMT3AWT in the DNMT3AWT–CGT complex (89.9 Å2 vs
a
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Fig. 4 Structural comparison of the DNMT3AWT–CGT and DNMT3AR882H–CGT complexes. a Structural superposition of the DNMT3AWT–CGT (PDB
5YX2) and DNMT3AR882H–CGT complexes. b Close-up view of protein–DNA interactions on the RD interface of the DNMT3AWT–CGT and
DNMT3AR882H–CGT complexes. c Close-up view of the TRD loop and its interactions with CpG guanine (G6) and R882 in the DNMT3AWT–CGT and
DNMT3AR882H–CGT complexes in expanded view. The hydrogen-bonding interactions are indicated by dashed lines. The conformational shifts of the DNA
between the two complexes are validated by the 1.0 sigma Fo–Fo difference map (salmon) between the two complexes and indicated by arrows. d, e Close-
up view of the interactions between the TRD loop and DNA in the DNMT3AWT–CGT (PDB 5YX2) (d) and DNMT3AR882H–CGT (e) complexes. The Fo–Fc
omit map (violet) for the corresponding regions were contoured at 2.0 sigma level.
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62.5 Å2), despite their similar resolution and crystallization packing.
Nevertheless, such structural and dynamic changes between the two
complexes reinforce the notion on the interplay between the
dynamics of TRD loop and DNA binding24, and suggest an
impairment of CpG recognition in the DNMT3AR882H–CGT
complex.
Structural analysis of the DNMT3AR882H–CAG DNA complex.
It has been established that DNMT3A not only mediates CpG
methylation, but also catalyzes non-CpG methylation, with the
enzymatic preference following an order of CpG > CpA > CpT29–33.
We therefore asked how the conformation of the TRD loop of
DNMT3AR882H interplays with non-CpG DNA. To address this
question, we determined a 2.45 Å-resolution crystal structure of
DNMT3AR882H–DNMT3L tetramer in complex with SAH and a
25-mer DNA duplex containing two separate ZpApG sites, mimic of
two CpApG sites (Fig. 5a,b and Supplementary Table 1). Structural
alignment of the entire DNMT3AR882H–DNMT3L–CAG DNA
(DNMT3AR882H–CAG) complex with the DNMT3AR882H–CGT
and DNMT3AR882H–CGA complexes gives an RMSD of 0.40 Å and
0.41 Å over 845 an 827 aligned Cα atoms, respectively, highlighting
their structural similarity (Fig. 5b). Consistently, structural com-
parison of the three DNMT3AR882H–DNA complexes reveals
similar DNA binding sites, formed by the catalytic loop, TRD loop
and the RD interface (Fig. 5b). In particular, the catalytic loop in the
DNMT3AR882H–DNMT3L–CAG DNA complex is well aligned
with the corresponding region in the CGT and CGA DNA com-
plexes, with residue V716 moving into the DNA cavity vacated by
the base flipping of zebularine to stack against the ZpA adenosine
(A6) (Fig. 5b and Supplementary Fig 4b,c). Nevertheless, due to the
different base ring sizes, A6 in the CAG complex engages less van
der Waals contact with the catalytic loop residues (V716 and P718)
than the corresponding G6 in the CGA and CGT complexes
(Fig. 5c–e), which may contribute to the reduced methylation effi-
ciency of DNMT3A on CpA over CpG. Furthermore, the RD
ec d
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Fig. 5 Structural analysis of the DNMT3AR882H–CAG complex. a DNA sequence (CAG) used for the structural study. b Structural superposition of the
DNMT3AR882H–CGA, DNMT3AR882H–CGT and DNMT3AR882H–CAG complexes, with the aligned catalytic loops, TRD loops and RD interfaces shown in
expanded views. The side chains of the DNA-contacting residues are shown in stick representation. c–e van der Waals contacts between the catalytic loop
(V716 and P718) and the nucleotide downstream of the methylation site (G6 or A6) in the DNMT3AR882H–CGA (c), DNMT3AR882H–CGT (d) and
DNMT3AR882H–CAG (e) complexes. f Close-up views of the interaction between TRD residue R836, with two alternative conformations, and the CAG
DNA. The hydrogen-bonding interactions are shown as dashed lines.
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interface is also well aligned among the three complexes, with the
side chain of residue H882 poised in a similar conformation
(Fig. 5b). Accordingly, the protein–DNA contact at the RD interface
of the DNMT3AR882H–CAG complex leads to a buried surface area
of ~207 Å2, comparable with that in the DNMT3AR882H–CGT and
DNMT3AR882H–CGA DNA complexes. The structural similarity
between the CpA and CpG DNA complexes of DNMT3AR882H
indicate that DNMT3A mediates CpA methylation in a similar
fashion as it does for the CpG methylation, highlighting its con-
served catalytic mechanism in DNA methylation, as well as the
structural rigidity of the DNMT3AR882H–DNMT3L tetramer.
Similar to what was observed for the DNMT3AR882H–CGA
complex, the side chain of R836 points toward the +1 – +2
flanking nucleotides, albeit with two alternative conformations:
one R836 conformer approaches the O4 atom of T8 for hydrogen
bond formation, while the other points toward the backbone
phosphate of G7 to form a salt bridge (Fig. 5b,f). However, unlike
the DNMT3AR882H–CGA DNA complex in which N838 forms
base-specific hydrogen bond with CpG guanine, the equivalent
residue in the DNMT3AR882H–CAG complex is not involved in
any contact with DNA (Fig. 5b and Supplementary Fig. 4d).
These observations further suggest the conformational flexibility
of the TRD loop of DNMT3AR882H in accommodating the DNA
substrates in different sequence contexts, and reinforce the notion
that enhanced conformational dynamics of the TRD loop by the
R882H mutation impairs CpG-specific DNA methylation. It is
worth noting that a water-mediated hydrogen bond is formed
between the side chain of T834 and the N7 atom of A6 in the
DNMT3AR882H–CAG complex (Supplementary Fig. 4d), resem-
bling the interaction between T834 and the CpG guanine in the
DNMT3A–CpG complexes (Figs. 1d and 3d)24. Given the fact
that a thymine base lacks the corresponding N7 group, this
interaction may underpin the differential methylation efficiency
of DNMT3A on CpA- and CpT-containing DNAs.
Structural integrity of the RD interface. Structural analysis of
the three DNMT3AR882H–DNA complexes reveals that the
RD interface is maintained in the same fashion as the
DNMT3AWT–DNA complexes, dominated by the reciprocal salt
bridges formed between residue R885 from one DNMT3A
monomer and residue D876 from the symmetry-related mate
(Supplementary Fig. 5a–e). These observations therefore suggest
that the RD interface-mediated homodimerization is preserved in
DNMT3AR882H, consistent with previous biochemical studies
that this residue does not directly contribute to the formation of
DNMT3A homodimer in the context of the DNMT3A–DNMT3L
tetramer24,26,27. The caveat of this observation is that it concerns
only the structure of DNTM3AR882H complexed with DNMT3L,
a regulatory factor that is under-expressed in somatic tissues8.
Therefore, the effect of the R882H mutation on the oligomer-
ization of DNMT3A in hematopoietic stem cells awaits further
investigation.
DNA-binding and enzymatic analysis of DNMT3AR882H.
Given that the structures of the DNMT3AR882H–DNA complexes
suggest that the R882H mutation might lead to impaired DNA
contact at both the RD interface and the TRD loop, we next
performed biochemical and enzymatic analyses to evaluate the
functional consequence of the R882H mutation. First, we com-
pared the DNA binding activities of the DNMT3AWT–DNMT3L
tetramer and DNMT3AR882H–DNMT3L tetramer for a 36-mer
CpG DNA using electrophoretic mobility shift assay (EMSA).
Consistent with what previously reported27, titration of the DNA
with the DNMT3AWT–DNMT3L tetramer led to the appearance
of multiple slow-mobility bands that correspond to the
DNMT3AWT–DNMT3L–DNA complexes with various stoi-
chiometric ratios (Fig. 6a). By contrast, significantly reduced
gel shift was observed for the DNMT3AR882H–DNMT3L tetra-
mer (Fig. 6a). Furthermore, we performed isothermal titration
calorimetry (ITC) binding assays to compare the binding affi-
nities of DNMT3AWT–DNMT3L and DNMT3AR882H–DNMT3L
for a 24-mer CpG DNA. DNMT3AWT–DNMT3L binds to the
DNA with dissociation constant (Kd) of 9.8 μM; under the same
experimental condition, no appreciable DNA binding was
observed for DNMT3AR882H–DNMT3L (Fig. 6b). Together, these
data confirm that the R882H mutation leads to reduced DNA-
binding affinity of DNMT3A.
Next, we performed in vitro enzymatic analysis to evaluate the
effect of the R882H mutation on the enzymatic activity and
specificity of DNMT3A. Toward this, we measured the enzymatic
activities of DNMT3AWT–DNMT3L and DNMT3AR882H–
DNMT3L on CG-, CA- and CT-containing DNAs (Supplementary
Fig. 6c–g). Under the experimental condition, the R882H mutation
reduced the activity of DNMT3A on CG-containing DNA by
3.3-fold (Supplementary Fig. 6c), consistent with previous observa-
tions that this mutation reduces the enzymatic activity of
DNMT3A17,20–22,24. By contrast, the methylation activity of
DNMT3AR882H on CA-containing DNA was reduced by 1.3-fold,
and was increased by 1.3-fold on CT-containing DNA. (Supple-
mentary Fig. 6d). As a result, the relative preferences of DNMT3A
for CG/CA and CG/CT DNAs were reduced by 2.6- and 4.2-fold,
respectively (Fig. 6c). To evaluate the effect of the R882H mutation
on the DNMT3A activities toward CpG and non-CpG sites located
on the same DNA substrate, we also measured the enzymatic
activities of DNMT3AWT–DNMT3L and DNMT3AR882H–
DNMT3L on a 626-bp long DNA substrate, containing multiple
CpG, CpA, CpT, and CpC sites. To allow for accurate comparison
of CpG specificity, the protein levels and reaction times
for DNMT3AWT–DNMT3L and DNMT3AR882H–DNMT3L
were adjusted to achieve a similar level of CpG methylation.
After methylation reaction with DNMT3AWT–DNMT3L or
DNMT3AR882H–DNMT3L, the DNA substrates were subjected to
bisulfite sequencing analysis. As expected for the high CpG/non-
CpG specificity of DNMT3A24,29, the DNA substrates methylated
by DNMT3AWT–DNMT3L show dominant CpG methylation over
CpH (H=A, C, or T) methylation (Fig. 6d and Supplementary
Fig. 6h). In comparison, the DNA substrates methylated by
DNMT3AR882H–DNMT3L show more populated methylation
events on CpH sites, with significantly increased CpA and CpC
methylation (Fig. 6d and Supplementary Fig. 6h). Furthermore,
analysis of the relative methylation levels of the CGX (X=G, A, T
or C) motif in the DNA substrate also indicates that the R882H
mutation shifts the relative methylation efficiencies of
DNMT3AWT–DNMT3L toward the CG(G/A) sites (Supplementary
Fig. 6i), consistent with the observation in a recent report25.
Together, these data lend a strong support to the structural
observation that the R882H mutation results in impaired CpG
recognition of DNMT3A.
Discussion
DNA methylation is an essential epigenetic mechanism that cri-
tically regulates gene expression, genomic stability, and cell
lineage commitment. Dysregulation of DNA methyltransferases is
linked to a variety of human diseases, with DNMT3A mutations
particularly implicated in hematological cancers and DNMT3B
mutations associated with ICF syndrome34. A detailed under-
standing of the structural and functional consequences of
DNMT3A or DNMT3B mutations is vital to deciphering their
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pathological effect, which will ultimately benefit the development
of novel therapeutic strategies against diseases. This study,
through structural and biochemical characterizations of
DNMT3AR882H–DNA interaction, reveals multiple functional
impacts of the AML-associated hotspot mutation DNMT3A
R882H: The R882H mutation not only reduced the protein–DNA
interactions at the RD interface, but also impairs the TRD loop-
mediated CpG recognition, which may together contribute to
aberrant CpG methylation in AML.
Importantly, this study uncovers the interplay between the
intrinsic conformational dynamics of the TRD loop of DNMT3A
and its CpG recognition. In particular, the DNMT3AWT-CGA
complex presented in this study, along with the DNMT3AWT–CGT
complex we reported previously24, reveals that residues R836-N838
of the TRD loop adopt different conformations when binding to
DNA substrates with different sequence contexts, highlighting the
conformational flexibility of this region. In the DNMT3AWT–CGT
complex, R836 forms a base-specific hydrogen bond with the O6
atom of CpG guanine, which ensures the CpG specificity, as
described previously24. However, in the DNMT3AWT–CGA com-
plexes, R836 turns away from the CpG site to form a hydrogen
bond with the +1A, as well as +2 or +3 flanking nucleotides.
Meanwhile, the side chain of N838 turns to the position vacated by
the side chain of R836 to form the base-specific hydrogen bond
with the O6 atom of CpG guanine, which presumably compensates
for the loss of R836-medated CpG recognition. Conceivably, these
alternative CpG recognition modes provide a mechanism by which
DNMT3A senses the flanking sequence of CpG sites, which may
play a role in fine-tuning the DNA methylation patterns across the
genome. A full understanding of these alternative CpG recognition
modes awaits further investigation.
This study also reveals the crosstalk between the RD interface
and the TRD loop of DNMT3A. Introduction of the R882H
mutation reduces the interactions between the RD interface and
DNA. As a result, the DNA molecule in the DNMT3AR882H–DNA
complex bends further away from the RD interface, and the
hydrogen bond between R882 and S837 becomes disrupted. These
structural changes may together contribute to the mobilization of
the TRD loop, thereby impairing the context-dependent CpG
recognition by DNMT3A. Along the line, the enzymatic preference
toward the flanking sequences of CpG target sites has previously
been observed for both DNMT3A and DNMT3B35–38, yet the
mechanism remains unclear. The enzymatic analysis in this study
not only supports an earlier notion that the DNMT3A R882H
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Fig. 6 Biochemical and enzymatic analyses of the DNMT3AR882H–DNA interaction. a EMSA gel image of the DNA binding activities of WT and R882H-
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mutation shifts the enzymatic preference of DNMT3A toward a
purine (G or A) on the +1 flanking site25 (Supplementary Fig. 6d),
but also indicates that the R882H mutation reduces the CpG/CpH
specificity of DNMT3A, both of which presumably impact the
DNA methylation landscape across the genome25. Importantly, the
crosstalk between the RD interface and the TRD loop provides a
mechanism by which the R882H mutation affects the substrate
specificity of DNMT3A. It is also conceivable that similar con-
formational changes in the TRD loop and RD interface can also be
induced by the R882C mutation, a second most prominent mis-
sense mutation of DNMT3A in AML, and other R882 mutations13.
The observation that the DNMT3A R882H mutation impacts
the context-dependent DNA methylation suggests this mutation
might impair the cellular CpG methylation through multiple
pathways (Fig. 6e): (1) the R882H mutation directly reduces the
CpG methylation activity of DNMT3A; (2) the R882H mutation
may influence the flanking sequence preference of DNMT3A,
resulting in aberrant DNA methylation patterns; and (3) the
R882H mutation may shift the events of the cytosine methylation
toward non-CpG methylation, which would be subjected to
immediate elimination during replication-dependent main-
tenance DNA methylation by DNMT1, an enzyme that shows
strict CpG specificity5,39–42. Collectively these functional defects
of the R882H-mutated DNMT3A might contribute to the aber-
rant DNA methylation in AML.
Methods
Protein expression and purification. DNA fragments encoding the C-terminal
domains of WT or R882H-mutated DNMT3A (residues 628-912) and DNMT3L
(residues 178-386) were inserted in tandem into pRSFDuet-1 vector (Novagen)
containing an N-terminal His6-SUMO tag (See Supplementary Table 2 for primer
information). The DNMT3AWT–DNMT3L and DNMT3AR882H–DNMT3L com-
plexes were expressed in Escherichia coli BL21 DE3 (RIL) cells, as described pre-
viously24, followed by purification using a Ni2+-NTA affinity column, with buffer
A (50 mM Tris-HCl, pH 8.0, 1 M NaCl and 25 mM imidazole) used for sample
loading and wash, and buffer B (50 mM Tris-HCl, pH 8.0, 1 M NaCl and 300 mM
imidazole) for elution. Upon removing the His6-SUMO tag via Ubiquitin-like
protease 1 (ULP1)-mediated cleavage the protein complex was further purified via
100–600 mM NaCl gradient on a Heparin column (low salt buffer: 25 mM Tris-
HCl, pH 8.0, and 100 mM NaCl; high salt buffer: 25 mM Tris-HCl, pH 8.0, and 1M
NaCl), and size-exclusion chromatography on a 16/600 Superdex 200 pg column
(GE Healthcare) in buffer containing 20 mM Tris-HCl (pH 8.0), 100 mM NaCl,
0.1% β-mercaptoethanol and 5% glycerol. The purified DNMT3AWT-DNMT3L or
DNMT3AR882H-DNMT3L tetramer was concentrated to 0.3 mM and stored in
−80 °C freezer before use.
Preparation of enzyme-substrate covalent complexes. 25-mer self-com-
plementary DNA sequences were used for generation of the DNMT3AR882H–
DNMT3L–CGT (CGT DNA: 5′-GCATGZGTTCTAATTAGAACGCATG-3′; Z=
zebularine), DNMT3AWT–DNMT3L–CGA and DNMT3AR882H–DNMT3L–CGA
(CGA DNA: 5′-CATGZGATCTAATTAGATCGCATGG-3′; Z= zebularine) and
DNMT3AR882H–DNMT3L–CAG (CAG DNA: 5′-CATGZAGTCTAATTAGACT
GCATGG-3′; Z= zebularine) complexes. The DNA molecules were first subject
to a denaturation and annealing process to generate duplexed DNA samples.
Subsequently, the DNA was incubated with the DNMT3AWT–DNMT3L or
DNMT3AR882H–DNMT3L tetramer in a 1:1 molar ratio to allow complex formation
in a buffer containing 20mM Tris-HCl (pH 8.0), 20% glycerol and 40mM DTT. The
reaction products were sequentially purified via 100–600mM NaCl gradient on a
HiTrap Q XL column (GE Healthcare) (low salt buffer: 25mM Tris-HCl, pH 8.0,
20mM DTT and 100mM NaCl; high salt buffer: 25mM Tris-HCl, pH 8.0, 20mM
DTT and 1M NaCl) and size-exclusion chromatography on a 16/600 Superdex
200 pg column (GE Healthcare) in buffer containing 20mM Tris-HCl (pH 8.0),
100mM NaCl, 0.1% β-mercaptoethanol and 5% glycerol. The final protein samples of
the DNMT3AWT–DNMT3L–DNA and DNMT3AR882H–DNMT3L–DNA complexes
were concentrated to 0.1mM and used for crystallization.
Crystallization conditions and structure determination. Crystals for
DNMT3AWT–DNMT3L–CGA, DNMT3AR882H–DNMT3L–CGA and
DNMT3AR882H–DNMT3L–CGT complexes were generated using hanging-drop
vapor-diffusion method at 4 °C, from drops containing 0.2 µL of 0. 1 mM complex
sample mixed with 0.8 µL of precipitant solution (0.1 M Sodium Citrate pH 4.2, 1%
PEG8000). Crystals for the DNMT3AR882H–DNMT3L–CAG complex were gen-
erated using hanging-drop vapor-diffusion method at 4 °C, from drops containing
0.5 µL of 0.1 mM DNMT3AR882H–DNMT3L–CAG complex sample and 0.5 µL of
precipitant solution (0.1 M Sodium Citrate pH 4.4, 0.2 % PEG8000). The crystals
were soaked in cryoprotectant made of mother liquor and 35% glycerol before
harvesting. X-ray diffractions datasets for the DNMT3AR882H–DNMT3L–CGA
complex were collected on the BL12-2 beamline at the Stanford Synchrotron
Radiation Light source (SSRL), SLAC National Accelerator Laboratory.
X-ray diffractions datasets for the DNMT3AWT–DNMT3L–CGA,
DNMT3AR882H–DNMT3L–CGT and DNMT3AR882H–DNMT3L–CAG complexes
were collected on the beamline 5.0.1 or 5.0.2 at the Advanced Light Source (ALS),
Lawrence Berkeley National Laboratory. The diffraction data were indexed, inte-
grated, and scaled using the HKL 3000 program43. The structures of the complexes
were solved by molecular replacement with the PHASER44 module in the PHNIEX
software package45, using the structure of DNMT3AWT–DNMT3L–CGT DNA
complex (PDB 5YX2) as search model. The structural models of the
DNMT3AWT–DNMT3L–CGA and DNMT3AR882H–DNMT3L–DNA complexes
were then subjected to modification using COOT46 and refinement using the
PHENIX software package45 in an iterative manner. The same R-free test set was
used throughout the refinement. The statistics for data collection and structural
refinement of the productive covalent DNMT3AWT–DNMT3L–CGA and
DNMT3AR882H–DNMT3L–DNA complexes are summarized in Supplementary
Table 1.
In vitro radioactivity-based methylation assay. In vitro methylation assay was
performed in triplicates using 20-µL reactions containing 1 µM protein (either
DNMT3AWT–DNMT3L or DNMT3AR882H–DNMT3L), 1 µM 36-mer DNA sub-
strate with a single CG, CA, or CT site (5′-AATAATAATAATAATAACXATA
ATAATAATAATAAA-3′, X=G, A or T), 2.5 µM S-adenosyl-L-[methyl-3H]
methionine with a specific activity of 18 Ci/mmol (PerkinElmer), 1.96 µM non-
radioactive SAM, 50 mM Tris-HCl (pH 7.5), 0.05% β-mercaptoethanol, 5% glycerol
and 200 µg/mL BSA. Reactions were left to proceed for 1 hour or indicated times at
37 °C and stopped by adding 5 µL of 10 mM nonradioactive SAM to each reaction.
Samples were loaded onto DEAE membrane, washed three times with 0.2 M
ammonium bicarbonate (pH 8.2), once with deionized water, and once with 95%
ethanol. The membrane was left to dry for 1 hour, cut into squares to separate
samples and soaked in a vial containing 4 mL of scintillation buffer. The incor-
poration of tritium onto DNA substrates was measured using Beckman LS6500
counter.
Electrophoretic mobility shift assay. DNA binding analysis was conducted using
20 nM DNA duplex containing (GAC)12 repeats which was titrated with either
DNMT3AWT–DNMT3L or DNMT3AR882H–DNMT3L, with protein concentra-
tions ranged from 0 to 600 nM. The binding buffer contained 50 mM Tris-HCl (pH
7.5), 5% glycerol and 1 mM DTT. Samples were resolved on a 4-15% wt/v poly-
acrylamide gel, which was run at 4 °C using 17.8 mM Tris–borate (pH 8.3) and
0.4 mM EDTA running buffer.
Bisulfite sequencing analysis of CpG and CpH methylation. A 626-bp long
DNA substrate (denoted herein as GST3), containing 15 CpG, 38 CpA, 26 CpT,
and 29 CpC sites, was amplified from one DNA fragment of the cDNA sequence
encoding glutathione S-transferase gene. 0.05 µM GST3 was incubated in a
methylation reaction buffer containing 400 µM SAM (S-adenosyl-L-methionine),
50 mM Tris-HCl pH 7.5, 0.05% β-mercaptoethanol and 5% glycerol in the absence
or presence of either 5 µM DNMT3AR882H–DNMT3L for 3 h. or 1 µM WT
DNMT3AWT–DNMT3L for 0.5 h. After incubation, the reactions were stopped by
immersing samples in liquid nitrogen. The samples were subjected to bisulfite
conversion using EZ DNA Methylation Gold Kit (ZYMO Research). Subsequently
the upper strand of the GST3 DNA substrate was PCR amplified, cloned into
pCR™4-TOPO™ TA Vector (Invitrogen), and sequenced to determine the level of
CpG, CpA, CpT, and CpC methylation. The experiments were performed with two
biological replicates. For replicate 1, 34 DNA clones were sequenced for methy-
lation analysis of each protein; for replicate 2, 7 DNA clones were sequenced for
methylation analysis of each protein. Comparable CpG methylation levels (20–
25%) between the samples were obtained for analysis. As control, the GST3 DNA
incubated in the absence of protein was subjected to bisulfite conversion, PCR
amplification and cloning analysis. A bisulfite conversion rate of 98.2% was
determined by the control experiment.
ITC measurements. DNA duplex containing (GAC)8 repeats was used to titrate
against DNMT3AWT-DNMT3L or DNMT3AR882H-DNMT3L. Both protein and
DNA samples were dialyzed against the ITC buffer (20 mM Tris-HCl, pH 7.5,
100 mM NaCl, 5% glycerol) at 4 °C overnight. A MicroCal iTC200 system (GE
Healthcare) was used to conduct the ITC measurements. A total of 20 injections
with a spacing of 180 s and a reference power of 5 μcal/s were performed at 4 °C.
The ITC curves were processed with software ORIGEN (MicroCal) using one-site
fitting model.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Data availability
Coordinates and structure factors for DNMT3AWT-DNMT3L-CGA DNA,
DNMT3AR882H-DNMT3L-CGA DNA, DNMT3AR882H-DNMT3L-CGT DNA,
DNMT3AR882H-DNMT3L-CAG DNA complexes have been deposited in the Protein
Data Bank under accession codes 6W8B, 6W89, 6W8D, and 6W8J, respectively. The
source data underlying Fig. 6a,c,d and Supplementary Figs 6e-h are provided as a Source
Data file. Other data are available from the corresponding author upon reasonable
request.
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